JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142073

AGK2, sirtuin2 (SIRT2) inhibitor

Be the first to review this product! Submit a review

|

(1 Publication)

MW 434.3 Da, Purity >95%. Selective reversible cell-permeable sirtuin2 (SIRT2) inhibitor (IC50 = 3.5 μM). Protects dopamine neurons from α-synuclein toxicity in vivo. Orally active.

View Alternative Names

FLJ35621, FLJ37491, NAD-dependent deacetylase sirtuin-2, NAD-dependent protein deacetylase sirtuin-2, Regulatory protein SIR2 homolog 2, SIR2, S. cerevisiae, homolog-loke 2, SIR2-like protein 2, SIR2L, SIR2L2, SIRT 2, SIRT2_HUMAN, Silencing information regulator 2 like, Silent information regulator 2, Sir2 related protein type 2, Sirtuin (silent mating type information regulation 2 homolog) 2 (S.cerevisiae), Sirtuin 2, Sirtuin type 2

1 Images
Chemical Structure - AGK2, sirtuin2 (SIRT2) inhibitor (AB142073)
  • Chemical Structure

Lab

Chemical Structure - AGK2, sirtuin2 (SIRT2) inhibitor (AB142073)

2D chemical structure image of ab142073, AGK2, sirtuin2 (SIRT2) inhibitor

Key facts

CAS number

304896-28-4

Purity

>95%

Form

Solid

form

Molecular weight

434.3 Da

Molecular formula

C<sub>2</sub><sub>3</sub>H<sub>1</sub><sub>3</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub>

PubChem

2130404

Nature

Synthetic

Solubility

Soluble in DMSO to 10 mM

Biochemical name

2-Propenamide, 2-cyano-3-(5-(2,5-dichlorophenyl)-2-furanyl)-N-5-quinolinyl-

Biological description

Selective reversible cell-permeable sirtuin2 (SIRT2) inhibitor (IC50 = 3.5 μM). Protects dopamine neurons from α-synuclein toxicity in vivo. Orally active.

Canonical smiles

C1=CC2=C(C=CC=N2)C(=C1)NC(=O)C(=CC3=CC=C(O3)C4=C(C=CC(=C4)Cl)Cl)C#N

Isomeric smiles

C1=CC2=C(C=CC=N2)C(=C1)NC(=O)/C(=C/C3=CC=C(O3)C4=C(C=CC(=C4)Cl)Cl)/C#N

InChi

InChI=1S/C23H13Cl2N3O2/c24-15-6-8-19(25)18(12-15)22-9-7-16(30-22)11-14(13-26)23(29)28-21-5-1-4-20-17(21)3-2-10-27-20/h1-12H,(H,28,29)/b14-11+

InChiKey

SVENPFFEMUOOGK-SDNWHVSQSA-N

IUPAC Name

(E)-2-cyano-3-[5-(2,5-dichlorophenyl)furan-2-yl]-N-quinolin-5-ylprop-2-enamide

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1651 SIRT2 Inhibitor, AGK2. 1651-10 is the same size as the 10 mg size of ab142073.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SIRT2 also known as Sirtuin 2 is a member of the sirtuin family of proteins which are NAD+-dependent deacetylases known for regulating various cellular processes. SIRT2 has a molecular mass of approximately 43 kDa. Its expression is prominent in the cytoplasm but can also be found in the nucleus of cells particularly in the brain and liver tissues. The protein deacetylates various substrates influencing cellular processes including aging metabolism and neurodegeneration.
Biological function summary

SIRT2 contributes to the regulation of cellular homeostasis and stress responses. This protein acts as a deacetylase modulating the acetylation status of key proteins and participates in various signaling pathways. It functions as part of a larger protein complex and interacts with substrates that include tubulin and histones. These interactions help SIRT2 control processes such as cell cycle differentiation and proliferation indicating its importance in maintaining normal cellular function.

Pathways

SIRT2 plays an essential role in the insulin signaling pathway and the FoxO transcription factor pathway. In these pathways SIRT2 interacts with other sirtuins like SIRT1 which helps regulate metabolic homeostasis and oxidative stress responses. SIRT2's activity in deacetylating proteins such as p53 impacts cellular responses to DNA damage and genomic stability further integrating it into critical regulatory networks within the cell.

SIRT2 relates to neurodegenerative diseases like Parkinson's disease and metabolic disorders such as obesity. Its involvement in deacetylating alpha-synuclein links SIRT2 to Parkinson's disease pathogenesis. In metabolic disorders abnormalities in SIRT2 activity can affect glucose and lipid metabolism connecting it with proteins like acetyl-CoA carboxylase. Understanding SIRT2's function offers potential therapeutic targets for these conditions and highlights its importance in disease regulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Bioengineered 12:7975-7984 PubMed34565300

2021

Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor - like 2 and Sirtuin 2 signaling pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Deng,Min Huang,Hao Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com